Literature DB >> 2148084

Role of Mg++ in the mithramycin-DNA interaction: evidence for two types of mithramycin-Mg++ complex.

P Aich1, D Dasgupta.   

Abstract

Mithramycin(MTR, structure shown in Figure 1) [and the related compound Chromomycin A3(CHRA3)] are antitumor antibiotics which inhibit DNA dependent RNA polymerase activity via reversible interaction with DNA only in the presence of divalent metal ion such as Mg++. In order to understand the role of Mg++ in MTR-DNA interaction, absorbance and CD spectroscopic techniques are employed to study the binding of MTR to Mg++. These studies show: i) the drug alone binds to Mg++ and ii) two different types of drug-Mg++ complexes are formed at low(Complex I) and high(Complex II) ratios of the concentration of Mg++ and MTR. We propose that these two complexes would bind to the same DNA with different affinities and rates. This result suggests that the relative concentration of Mg++ is an important factor to be taken into account to understand the molecular basis of MTR-DNA interaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148084     DOI: 10.1016/s0006-291x(05)80090-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Effect of complex formation between Zn2+ ions and the anticancer drug mithramycin upon enzymatic activity of zinc(II)-dependent alcohol dehydrogenase.

Authors:  Suman Das; Pukhrambam Grihanjali Devi; Sudipta Pal; Dipak Dasgupta
Journal:  J Biol Inorg Chem       Date:  2004-11-18       Impact factor: 3.358

2.  Characterization of the terminal activation step catalyzed by oxygenase CmmOIV of the chromomycin biosynthetic pathway from Streptomyces griseus.

Authors:  Mary A Bosserman; Ana B Flórez; Khaled A Shaaban; Alfredo F Braña; Jose A Salas; Carmen Méndez; Jürgen Rohr
Journal:  Biochemistry       Date:  2011-02-02       Impact factor: 3.162

3.  Crystal structure of the [Mg2+-(chromomycin A3)2]-d(TTGGCCAA)2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion.

Authors:  Ming-Hon Hou; Howard Robinson; Yi-Gui Gao; Andrew H-J Wang
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

4.  Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins.

Authors:  Caixia Hou; Abhisek Mandal; Jürgen Rohr; Oleg V Tsodikov
Journal:  Structure       Date:  2020-12-03       Impact factor: 5.006

5.  Global gene expression profiling data analysis reveals key gene families and biological processes inhibited by Mithramycin in sarcoma cell lines.

Authors:  Kirti K Kulkarni; Kiran Gopinath Bankar; Rohit Nandan Shukla; Chandrima Das; Amrita Banerjee; Dipak Dasgupta; Madavan Vasudevan
Journal:  Genom Data       Date:  2014-11-08

6.  Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder.

Authors:  Amrita Banerjee; Sulagna Sanyal; Kirti K Kulkarni; Kuladip Jana; Siddhartha Roy; Chandrima Das; Dipak Dasgupta
Journal:  FEBS Open Bio       Date:  2014-10-16       Impact factor: 2.693

7.  Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1.

Authors:  Caixia Hou; Stevi Weidenbach; Kristin E Cano; Zhonghua Wang; Prithiba Mitra; Dmitri N Ivanov; Jürgen Rohr; Oleg V Tsodikov
Journal:  Nucleic Acids Res       Date:  2016-09-01       Impact factor: 16.971

8.  Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences.

Authors:  Francisca Barceló; Claudia Scotta; Miguel Ortiz-Lombardía; Carmen Méndez; José A Salas; José Portugal
Journal:  Nucleic Acids Res       Date:  2007-03-16       Impact factor: 16.971

9.  Mithramycin forms a stable dimeric complex by chelating with Fe(II): DNA-interacting characteristics, cellular permeation and cytotoxicity.

Authors:  Ming-Hon Hou; Andrew H-J Wang
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

Review 10.  Chromatin as a target for the DNA-binding anticancer drugs.

Authors:  Parijat Majumder; Suman K Pradhan; Pukhrambam Grihanjali Devi; Sudipta Pal; Dipak Dasgupta
Journal:  Subcell Biochem       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.